Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the cognitive effects of topiramate (TPM) and gabapentin (GBP). METHODS: Forty healthy volunteers were randomized to a 12-week course of TPM, GBP, or placebo. Doses were gradually escalated over 10 weeks to a maximum of 400 mg/day of TPM or 3,600 mg/day of GBP or to the highest tolerated dose. Subjects were interviewed and examined biweekly. Cognitive testing was performed prior to initiating the drug and again 12 weeks later, at least 2 weeks after achieving plateau dosing. For each subject and cognitive measure, test-retest Z scores were calculated based on regression equations derived from 73 healthy volunteers. Group comparisons utilized the Wilcoxon test. RESULTS: There were significant TPM vs GBP and TPM vs placebo differences in test-retest Z scores for four of six target cognitive measures (Digit Symbol, Story Recall, Selective Reminding, Controlled Oral Word Association), always indicating worse retest performance for subjects receiving TPM. Overall, 12 of 24 cognitive measures were similarly affected. TPM effects were large, and several target measures averaged >2 SD of negative change. One measure was significantly affected by GBP. CONCLUSIONS: Topiramate (TPM) impaired cognitive test performance, whereas gabapentin had minimal effects. The effects of TPM were of sufficient magnitude potentially to affect daily and occupational function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Attention and the detection of signals.
Posner, M. I., Snyder, C. R., & Davidson, B. J. (1980) · Journal of Experimental Psychology: General · doi:10.1037/0096-3445.109.2.160 · Cited by 3,778
Right hemisphere processing superiority during sustained visual attention
Whitehead, R. (1991) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.1991.3.4.329 · Cited by 88
Cited by
Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.10.008 · Cited by 477
Cognitive Effects of Antiepileptic Drugs
Park, S.-P., & Kwon, S.-H. (2008) · Journal of Clinical Neurology · doi:10.3988/jcn.2008.4.3.99 · Cited by 271
Cognitive side effects of antiepileptic drugs in children
Loring, D. W., & Meador, K. J. (2004) · Neurology · doi:10.1212/01.wnl.0000115653.82763.07 · Cited by 265
Mason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., Buffkins, K., Kyle, M., Adusumalli, M., Begovic, A., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.14 · Cited by 242
Gabapentin for the treatment of alcohol use disorder
Mason, B. J., Quello, S., & Shadan, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1417383 · Cited by 104
Metadata
- Authors
- Salinsky, M. C., Storzbach, D., Spencer, D. C., Oken, B. S., Landry, T., & Dodrill, C. B.
- Venue
- Neurology
- Published
- 2005-03-08
- Volume
- 64
- Issue
- 5
- Pages
- 792-798
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2153884620
- Cited by
- 116
- References
- 2
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. https://app.cochat.ai/papers/10.1212/01.wnl.0000152877.08088.87
- The paper
- Salinsky, M. C., Storzbach, D., Spencer, D. C., Oken, B. S., Landry, T., & Dodrill, C. B. (2005). Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology. https://doi.org/10.1212/01.wnl.0000152877.08088.87
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.